FISH analyses on the paired GSC xenografts demonstrated amplified and non-amplified EGFR in pre- and post-dacomitinib tumours, respectively, which reflected the differential EGFR expression levels on immunohistochemistry. The gene discussed is EGFR; the disease is neoplasm.